MOLINA HEALTHCARE INC (MOH) Fundamental Analysis & Valuation

NYSE:MOH • US60855R1005

Current stock price

146.49 USD
-2.71 (-1.82%)
At close:
146.49 USD
0 (0%)
After Hours:

This MOH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MOH Profitability Analysis

1.1 Basic Checks

  • In the past year MOH was profitable.
  • MOH had a negative operating cash flow in the past year.
  • MOH had positive earnings in each of the past 5 years.
  • Of the past 5 years MOH 4 years had a positive operating cash flow.
MOH Yearly Net Income VS EBIT VS OCF VS FCFMOH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B 1.5B 2B

1.2 Ratios

  • MOH's Return On Assets of 3.03% is fine compared to the rest of the industry. MOH outperforms 65.35% of its industry peers.
  • MOH has a better Return On Equity (11.60%) than 78.22% of its industry peers.
  • MOH's Return On Invested Capital of 7.39% is fine compared to the rest of the industry. MOH outperforms 70.30% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MOH is significantly above the industry average of 8.92%.
  • The 3 year average ROIC (14.32%) for MOH is well above the current ROIC(7.39%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROIC 7.39%
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
MOH Yearly ROA, ROE, ROICMOH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

1.3 Margins

  • MOH has a Profit Margin (1.04%) which is in line with its industry peers.
  • MOH's Profit Margin has declined in the last couple of years.
  • MOH has a Operating Margin (1.73%) which is comparable to the rest of the industry.
  • MOH's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 13.07%, MOH is doing worse than 67.33% of the companies in the same industry.
  • MOH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
MOH Yearly Profit, Operating, Gross MarginsMOH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MOH Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MOH is creating some value.
  • The number of shares outstanding for MOH has been reduced compared to 1 year ago.
  • Compared to 5 years ago, MOH has less shares outstanding
  • Compared to 1 year ago, MOH has a worse debt to assets ratio.
MOH Yearly Shares OutstandingMOH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
MOH Yearly Total Debt VS Total AssetsMOH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 4.20 indicates that MOH is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of MOH (4.20) is better than 78.22% of its industry peers.
  • A Debt/Equity ratio of 0.97 indicates that MOH is somewhat dependend on debt financing.
  • MOH's Debt to Equity ratio of 0.97 is in line compared to the rest of the industry. MOH outperforms 41.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 4.2
ROIC/WACC0.92
WACC7.99%
MOH Yearly LT Debt VS Equity VS FCFMOH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 1.69 indicates that MOH should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.69, MOH is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
  • MOH has a Quick Ratio of 1.69. This is a normal value and indicates that MOH is financially healthy and should not expect problems in meeting its short term obligations.
  • MOH's Quick ratio of 1.69 is fine compared to the rest of the industry. MOH outperforms 70.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
MOH Yearly Current Assets VS Current LiabilitesMOH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. MOH Growth Analysis

3.1 Past

  • MOH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.98%.
  • MOH shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.02% yearly.
  • MOH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.75%.
  • MOH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.52% yearly.
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%

3.2 Future

  • The Earnings Per Share is expected to grow by 21.69% on average over the next years. This is a very strong growth
  • MOH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.17% yearly.
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MOH Yearly Revenue VS EstimatesMOH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B
MOH Yearly EPS VS EstimatesMOH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

3

4. MOH Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 13.75 indicates a correct valuation of MOH.
  • Compared to the rest of the industry, the Price/Earnings ratio of MOH indicates a rather cheap valuation: MOH is cheaper than 84.16% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.96, MOH is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 18.84 indicates a rather expensive valuation of MOH.
  • Based on the Price/Forward Earnings ratio, MOH is valued a bit cheaper than 61.39% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, MOH is valued a bit cheaper.
Industry RankSector Rank
PE 13.75
Fwd PE 18.84
MOH Price Earnings VS Forward Price EarningsMOH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.64
MOH Per share dataMOH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 400 600 800

4.3 Compensation for Growth

  • MOH's earnings are expected to grow with 13.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.58%
EPS Next 3Y13.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MOH Dividend Analysis

5.1 Amount

  • MOH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MOH Fundamentals: All Metrics, Ratios and Statistics

MOLINA HEALTHCARE INC

NYSE:MOH (3/16/2026, 8:04:00 PM)

After market: 146.49 0 (0%)

146.49

-2.71 (-1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-05
Earnings (Next)04-22
Inst Owners105.33%
Inst Owner Change-7.91%
Ins Owners1.33%
Ins Owner Change10.61%
Market Cap7.54B
Revenue(TTM)45.43B
Net Income(TTM)472.00M
Analysts65
Price Target156.67 (6.95%)
Short Float %6.99%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-484.67%
Min EPS beat(2)-916.01%
Max EPS beat(2)-53.34%
EPS beat(4)1
Avg EPS beat(4)-243.64%
Min EPS beat(4)-916.01%
Max EPS beat(4)1.06%
EPS beat(8)4
Avg EPS beat(8)-122.21%
EPS beat(12)7
Avg EPS beat(12)-79.46%
EPS beat(16)11
Avg EPS beat(16)-58.81%
Revenue beat(2)2
Avg Revenue beat(2)3.86%
Min Revenue beat(2)3.74%
Max Revenue beat(2)3.99%
Revenue beat(4)4
Avg Revenue beat(4)3.29%
Min Revenue beat(4)2.13%
Max Revenue beat(4)3.99%
Revenue beat(8)8
Avg Revenue beat(8)2.71%
Revenue beat(12)10
Avg Revenue beat(12)2.28%
Revenue beat(16)14
Avg Revenue beat(16)2.34%
PT rev (1m)-12.12%
PT rev (3m)-10.16%
EPS NQ rev (1m)-29.32%
EPS NQ rev (3m)-38.77%
EPS NY rev (1m)-44.06%
EPS NY rev (3m)-42.68%
Revenue NQ rev (1m)-1.94%
Revenue NQ rev (3m)-5.23%
Revenue NY rev (1m)-4%
Revenue NY rev (3m)-4.35%
Valuation
Industry RankSector Rank
PE 13.75
Fwd PE 18.84
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 1.85
P/tB 4.03
EV/EBITDA -0.64
EPS(TTM)10.65
EY7.27%
EPS(NY)7.78
Fwd EY5.31%
FCF(TTM)-12.35
FCFYN/A
OCF(TTM)-10.39
OCFYN/A
SpS882.06
BVpS79.01
TBVpS36.39
PEG (NY)N/A
PEG (5Y)N/A
Graham Number137.6
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 11.6%
ROCE 9.57%
ROIC 7.39%
ROICexc N/A
ROICexgc N/A
OM 1.73%
PM (TTM) 1.04%
GM 13.07%
FCFM N/A
ROA(3y)5.97%
ROA(5y)5.95%
ROE(3y)21.24%
ROE(5y)23.1%
ROIC(3y)14.32%
ROIC(5y)15.99%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.55%
ROCE(5y)20.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.35%
OM growth 5Y-21.51%
PM growth 3Y-25.14%
PM growth 5Y-21.41%
GM growth 3Y-4.5%
GM growth 5Y-6.76%
F-Score4
Asset Turnover2.92
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 51.79%
Cap/Sales 0.22%
Interest Coverage 4.33
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 4.2
F-Score4
WACC7.99%
ROIC/WACC0.92
Cap/Depr(3y)51.56%
Cap/Depr(5y)53.03%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.98%
EPS 3Y-15.91%
EPS 5Y-0.02%
EPS Q2Q%-154.46%
EPS Next Y-26.98%
EPS Next 2Y1.58%
EPS Next 3Y13.62%
EPS Next 5Y21.69%
Revenue 1Y (TTM)11.75%
Revenue growth 3Y12.42%
Revenue growth 5Y18.52%
Sales Q2Q%8.34%
Revenue Next Year0%
Revenue Next 2Y3.1%
Revenue Next 3Y3.89%
Revenue Next 5Y4.17%
EBIT growth 1Y-54.1%
EBIT growth 3Y-18.33%
EBIT growth 5Y-6.97%
EBIT Next Year-29.1%
EBIT Next 3Y6.7%
EBIT Next 5Y18.96%
FCF growth 1Y-216.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-183.07%
OCF growth 3YN/A
OCF growth 5YN/A

MOLINA HEALTHCARE INC / MOH Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MOLINA HEALTHCARE INC?

ChartMill assigns a fundamental rating of 4 / 10 to MOH.


What is the valuation status of MOLINA HEALTHCARE INC (MOH) stock?

ChartMill assigns a valuation rating of 3 / 10 to MOLINA HEALTHCARE INC (MOH). This can be considered as Overvalued.


How profitable is MOLINA HEALTHCARE INC (MOH) stock?

MOLINA HEALTHCARE INC (MOH) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for MOH stock?

The Price/Earnings (PE) ratio for MOLINA HEALTHCARE INC (MOH) is 13.75 and the Price/Book (PB) ratio is 1.85.